Variant Human Immunodeficiency Virus Type 1 Proteases and Response to Combination Therapy Including a Protease Inhibitor

The objective of this observational study was to assess the genetic variability in the human immunodeficiency virus (HIV) protease gene from HIV type 1 (HIV-1)-positive (clade B), protease inhibitor-naïve patients and to evaluate its association with the subsequent effectiveness of a protease inhibi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Servais, Jean, Lambert, Christine, Fontaine, Elodie, Plesséria, Jean-Marc, Robert, Isabelle, Arendt, Vic, Staub, Thérèse, Schneider, François, Hemmer, Robert, Burtonboy, Guy, Schmit, Jean-Claude
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90389/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181376/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.893-900.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!